Suresh Durgam
2 presentations
-
W38. EFFICACY OF LUMATEPERONE 42 MG FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: ANALYSIS OF DEMOGRAPHIC AND CLINICAL SUBGROUPS IN A PHASE 3 RANDOMIZED PLACEBO-CONTROLLED TRIAL
-
T40. ADJUNCTIVE LUMATEPERONE 42 MG TREATMENT IN MAJOR DEPRESSIVE DISORDER: EFFICACY ACROSS PATIENT-REPORTED DEPRESSION SYMPTOMS